Datwyler’s Elastomer Components Manufacturing Facility, Middletown, Delaware, United States of America

Datwyler Invests in Elastomer Componant

Switzerland-based industrial supplier Datwyler has announced a CHF100m ($102m) investment in a new elastomer component manufacturing plant in Delaware, US.

The proposed plant will be located in Middletown in Delaware and it will manufacture elastomer components for injectable drug delivery systems. It will be the company's second manufacturing plant in the US, while its first plant has been in operation since 1981.

Construction on the new plant is expected to begin before the end of 2016 and it is scheduled for completion in 2018. First production is expected by H2, 2018. The plant will create 120 jobs when fully-operational.

Design and construction of the automated production facility

The manufacturing facility will have a built-up area of more than 275,000ft². Civil Engineering Associates has been chosen to provide designs and engineering services for the project.

Datwyler's new plant will be designed and constructed in accordance with the company's FirstLine standards, which includes the use of state-of-the-art systems comprising ultra-modern clean room, automated production cells, fully-automated camera inspection, and a unique washing process during production.

The innovative manufacturing concept helps deliver high-quality products, which exceed European and US quality standards. The FirstLine process is also certified to ISO 15378 standards.

Adoption of the innovative technology is expected to also enable the company to supply locally-made high-quality elastomer components to customers in Europe and Asia.

Datwyler's elastomeric and other components for drug delivery systems

Datwyler's sealing solutions for drug delivery systems include elastomeric closures for vials, elastomeric plunger stoppers, needle shields and tip caps to seal prefilled syringes, and plungers and rubber-lined aluminium seals for cartridges.

The company makes 13mm-32mm rubber stoppers, and aluminium caps and seals for glass vials used in the pharmaceutical industry.

The aluminium caps come in a number of design choices including flip and flush for smaller sealed vials, and finger and tear-off designs for large volume vials.

In addition, Datwyler makes pre-filled syringe components using advanced formulations based on halobutyl elastomers and lubricates them with silicon oil, with the option for a fluoropolymer coating for silicon oil-sensitive applications.

Marketing commentary on Datwyler

The Datwyler Group is an industrial supplier serving more than 100 countries and generating sales of approximately $1.21bn a year.

The group's sealing solutions division supplies customised solutions to a number of industries including automotive, healthcare, civil engineering, and consumer goods. Apart from solutions for drug delivery systems, the division makes components used in enhanced processing, medical devices and compounds in the healthcare industry.

The group also has another division named the technical components division, which distributes electronic and ICT, as well as automation components and accessories in Europe.